Bellwether Trials in Taxotere Lawsuit to Begin May 2019
Posted On: July 18, 2018 Posted In: Blog, Defective Drugs
On June 13th, the federal court overseeing thousands of Taxotere lawsuits ordered that bellwether trials will begin in May 2019. Taxotere (docetaxel) is a chemotherapy drug manufactured by Sanofi-Aventis. Recently, over 8,700 lawsuits have been filed alleging that alopecia (hair loss) caused by this drug is far more likely to be permanent compared to equally-effective alternative medications. All federally filed complaints have been centralized to proceed together in the Eastern District of Louisiana under Judge Jane T. Milazzo.